Jeremy R. Graff - 30 Sep 2025 Form 4 Insider Report for Allarity Therapeutics, Inc. (ALLR)

Reporting relationship: President and Chief Development Officer
Issuer ticker: ALLR
Reported as of: 30 Sep 2025
Net transaction value: -$23,089
SEC form: 4
Accepted by SEC: 02 Oct 2025, 16:05:10 UTC
Prior SEC filing: 12 May 2025
Next SEC filing: 16 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Jeremy R. Graff

Key filing fact

Jeremy R. Graff filed Form 4 for Allarity Therapeutics, Inc. (ALLR) on 02 Oct 2025.

Key facts

This page summarizes Jeremy R. Graff's Form 4 filing for Allarity Therapeutics, Inc. (ALLR).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 02 Oct 2025, 16:05.

Change

Previous filing in this sequence was filed on 12 May 2025.
Current net transaction value: -$23,089.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001975028 Primary reporting owner

Graff Jeremy R.

Relationship: President and Chief Development Officer
Address: C/O ALLARITY THERAPEUTICS, INC, 123 E TARPON AVE, TARPON SPRINGS
Signature: /s/ Jeremy R. Graff
Signature date: 02 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALLR transaction

Common Stock

Options Exercise

Transaction value
Shares: +39,494
Change %
Price
Shares after: 39,494
Date: 30 Sep 2025
Ownership: Direct
Footnotes: F1

ALLR transaction

Common Stock

Tax liability

Transaction value: $23,089
Shares: -14,613
Change %: -37%
Price: $1.58
Shares after: 24,881
Date: 30 Sep 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ALLR transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -39,494
Change %: -15%
Price: $0.000000
Shares after: 223,430
Date: 30 Sep 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 39,494
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Restricted stock units convert into common stock on a one-for-one basis.

Footnote F2

On September 30, 2024 and January 22, 2025, the Reporting Person was granted 118,483 and 144,441 restricted stock units, respectively, which vest in three equal annual installments beginning on the first anniversary of the applicable grant date.

SEC remarks

President and Chief Development Officer